LeMaitre Vascular ROA 2010-2025 | LMAT
Current and historical return on assets (ROA) values for LeMaitre Vascular (LMAT) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| LeMaitre Vascular ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-03-31 | $0.05B | $0.56B | 9.74% |
| 2024-12-31 | $0.04B | $0.55B | 10.69% |
| 2024-09-30 | $0.04B | $0.38B | 11.38% |
| 2024-06-30 | $0.04B | $0.36B | 10.87% |
| 2024-03-31 | $0.03B | $0.35B | 9.99% |
| 2023-12-31 | $0.03B | $0.35B | 9.08% |
| 2023-09-30 | $0.03B | $0.33B | 8.72% |
| 2023-06-30 | $0.03B | $0.33B | 7.98% |
| 2023-03-31 | $0.02B | $0.32B | 6.85% |
| 2022-12-31 | $0.02B | $0.31B | 6.98% |
| 2022-09-30 | $0.02B | $0.30B | 7.08% |
| 2022-06-30 | $0.02B | $0.30B | 7.84% |
| 2022-03-31 | $0.03B | $0.29B | 9.63% |
| 2021-12-31 | $0.03B | $0.29B | 10.04% |
| 2021-09-30 | $0.03B | $0.29B | 10.81% |
| 2021-06-30 | $0.03B | $0.25B | 11.50% |
| 2021-03-31 | $0.03B | $0.25B | 9.82% |
| 2020-12-31 | $0.02B | $0.25B | 9.21% |
| 2020-09-30 | $0.02B | $0.26B | 8.98% |
| 2020-06-30 | $0.02B | $0.26B | 8.51% |
| 2020-03-31 | $0.02B | $0.19B | 10.20% |
| 2019-12-31 | $0.02B | $0.19B | 11.16% |
| 2019-09-30 | $0.02B | $0.17B | 12.38% |
| 2019-06-30 | $0.02B | $0.16B | 12.26% |
| 2019-03-31 | $0.02B | $0.16B | 15.49% |
| 2018-12-31 | $0.02B | $0.15B | 16.34% |
| 2018-09-30 | $0.02B | $0.14B | 15.67% |
| 2018-06-30 | $0.02B | $0.14B | 17.15% |
| 2018-03-31 | $0.02B | $0.13B | 14.75% |
| 2017-12-31 | $0.02B | $0.13B | 14.59% |
| 2017-09-30 | $0.02B | $0.12B | 14.48% |
| 2017-06-30 | $0.01B | $0.11B | 13.27% |
| 2017-03-31 | $0.01B | $0.11B | 11.82% |
| 2016-12-31 | $0.01B | $0.10B | 11.22% |
| 2016-09-30 | $0.01B | $0.10B | 11.55% |
| 2016-06-30 | $0.01B | $0.10B | 10.90% |
| 2016-03-31 | $0.01B | $0.09B | 10.17% |
| 2015-12-31 | $0.01B | $0.09B | 9.38% |
| 2015-09-30 | $0.01B | $0.09B | 8.46% |
| 2015-06-30 | $0.01B | $0.08B | 7.32% |
| 2015-03-31 | $0.01B | $0.08B | 6.13% |
| 2014-12-31 | $0.00B | $0.08B | 5.08% |
| 2014-09-30 | $0.00B | $0.08B | 3.95% |
| 2014-06-30 | $0.00B | $0.08B | 4.18% |
| 2014-03-31 | $0.00B | $0.07B | 4.44% |
| 2013-12-31 | $0.00B | $0.07B | 6.06% |
| 2013-09-30 | $0.00B | $0.07B | 6.23% |
| 2013-06-30 | $0.00B | $0.06B | 6.37% |
| 2013-03-31 | $0.00B | $0.06B | 6.48% |
| 2012-12-31 | $0.00B | $0.06B | 4.94% |
| 2012-09-30 | $0.00B | $0.06B | 3.33% |
| 2012-06-30 | $0.00B | $0.06B | 3.31% |
| 2012-03-31 | $0.00B | $0.06B | 3.28% |
| 2011-12-31 | $0.00B | $0.06B | 3.25% |
| 2011-09-30 | $0.00B | $0.06B | 6.43% |
| 2011-06-30 | $0.01B | $0.06B | 8.10% |
| 2011-03-31 | $0.01B | $0.06B | 9.88% |
| 2010-12-31 | $0.01B | $0.06B | 11.72% |
| 2010-09-30 | $0.01B | $0.06B | 10.30% |
| 2010-06-30 | $0.01B | $0.06B | 8.77% |
| 2010-03-31 | $0.00B | $0.06B | 7.14% |
| 2009-12-31 | $0.00B | $0.06B | 1.83% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.848B | $0.220B |
| LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.381B | 27.82 |
| Boston Scientific (BSX) | United States | $149.868B | 37.52 |
| Stryker (SYK) | United States | $143.347B | 29.97 |
| EssilorLuxottica (ESLOY) | France | $128.152B | 0.00 |
| Medtronic (MDT) | Ireland | $110.735B | 15.70 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.273B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.835B | 26.69 |
| ResMed (RMD) | United States | $37.196B | 27.94 |
| Agilent Technologies (A) | United States | $32.827B | 21.40 |
| GE HealthCare Technologies (GEHC) | United States | $32.638B | 15.50 |
| Terumo (TRUMY) | Japan | $26.398B | 34.29 |
| Koninklijke Philips (PHG) | Netherlands | $21.463B | 15.06 |
| Insulet (PODD) | United States | $21.334B | 83.74 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.048B | 11.59 |
| Baxter (BAX) | United States | $15.390B | 11.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.627B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.442B | 22.42 |
| Lantheus Holdings (LNTH) | United States | $5.479B | 13.82 |
| Prestige Consumer Healthcare (PBH) | United States | $4.123B | 18.42 |
| Perrigo (PRGO) | Ireland | $3.643B | 9.23 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.415B | 15.55 |
| Envista Holdings (NVST) | United States | $3.202B | 26.61 |
| ICU Medical (ICUI) | United States | $3.144B | 23.18 |
| QuidelOrtho (QDEL) | United States | $1.896B | 13.04 |
| AtriCure (ATRC) | United States | $1.554B | 0.00 |
| Acuren (TIC) | United States | $1.324B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.132B | 11.49 |
| Neogen (NEOG) | United States | $1.072B | 13.72 |
| Green Thumb Industries (GTBIF) | United States | $1.042B | 23.43 |
| BioLife Solutions (BLFS) | United States | $1.008B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.968B | 12.37 |
| InMode (INMD) | Israel | $0.839B | 8.46 |
| Kestra Medical Technologies (KMTS) | United States | $0.772B | 0.00 |
| CeriBell (CBLL) | United States | $0.647B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Owens & Minor (OMI) | United States | $0.567B | 4.71 |
| Curaleaf Holdings (CURLF) | Canada | $0.531B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.525B | 0.00 |
| Valneva SE (VALN) | France | $0.478B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.377B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.362B | 0.00 |
| SNDL (SNDL) | Canada | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.319B | 11.74 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.288B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.262B | 22.07 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| ZimVie (ZIMV) | United States | $0.245B | 11.13 |
| Sanara MedTech (SMTI) | United States | $0.242B | 0.00 |
| Quanterix (QTRX) | United States | $0.238B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.229B | 68.00 |
| Canopy Growth (CGC) | Canada | $0.228B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Biote (BTMD) | United States | $0.217B | 6.09 |
| Cresco Labs (CRLBF) | United States | $0.212B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.212B | 0.00 |
| Brainsway (BWAY) | Israel | $0.206B | 54.55 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.174B | 14.19 |
| Verano Holdings (VRNOF) | United States | $0.174B | 0.00 |
| Organigram Global (OGI) | Canada | $0.173B | 0.00 |
| Exagen (XGN) | United States | $0.154B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.132B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.125B | 15.40 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Veru (VERU) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.34 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| MacroGenics (MGNX) | United States | $0.083B | 0.00 |
| Agape ATP (ATPC) | $0.079B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| Apyx Medical (APYX) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| ImmuCell (ICCC) | United States | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Nephros (NEPH) | United States | $0.053B | 71.43 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 12.98 |
| Rockwell Medical (RMTI) | United States | $0.030B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |